76
Views
11
CrossRef citations to date
0
Altmetric
Review

New treatments for genotype 1 chronic hepatitis C – focus on simeprevir

, , &
Pages 387-394 | Published online: 24 May 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Pravinkumar Vishwanath Ingle, Sarah Zakiah Samsudin, Pei Qi Chan, Mei Kei Ng, Li Xuan Heng, Siu Ching Yap, Amy Siaw Hui Chai & Audrey San Ying Wong. (2016) Development and novel therapeutics in hepatocellular carcinoma: a review. Therapeutics and Clinical Risk Management 12, pages 445-455.
Read now
Isabella Esposito, Pablo Labarga, Pablo Barreiro, José V Fernandez-Montero, Carmen de Mendoza, Laura Benítez-Gutiérrez, José M Peña & Vicente Soriano. (2015) Dual antiviral therapy for HIV and hepatitis C – drug interactions and side effects. Expert Opinion on Drug Safety 14:9, pages 1421-1434.
Read now

Articles from other publishers (9)

Rasha M. Ahmed, Marwa A. A. Fayed, Mohammed F. El-Behairy & Inas A. Abdallah. (2020) Identification, isolation, structural characterization, in silico toxicity prediction and in vitro cytotoxicity assay of simeprevir acidic and oxidative degradation products . RSC Advances 10:70, pages 42816-42826.
Crossref
Tatsuo Kanda, Kazushige Nirei, Naoki Matsumoto, Teruhisa Higuchi, Hitomi Nakamura, Hiroaki Yamagami, Shunichi Matsuoka & Mitsuhiko Moriyama. (2017) Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b. World Journal of Gastroenterology 23:46, pages 8120-8127.
Crossref
Helena H. Borba, Astrid Wiens, Laiza M. Steimbach, Cassio M. Perlin, Fernanda S. Tonin, Maria L. A. Pedroso, Fernando Fernandez-Llimos & Roberto Pontarolo. (2016) Network meta-analysis of first- and second-generation protease inhibitors for chronic hepatitis C genotype 1: efficacy based on RVR and SVR 24. European Journal of Clinical Pharmacology 73:1, pages 1-14.
Crossref
Elyse Swallow, Caroline Kelley, James Signorovitch, Gail Wygant & Fiona McPhee. (2016) Daclatasvir + asunaprevir versus sofosbuvir/ledipasvir for hepatitis C genotype 1 in Japanese patients: an indirect comparison. Journal of Comparative Effectiveness Research 5:3, pages 273-279.
Crossref
Rolando Cannalire, Maria Letizia Barreca, Giuseppe Manfroni & Violetta Cecchetti. (2015) A Journey around the Medicinal Chemistry of Hepatitis C Virus Inhibitors Targeting NS4B: From Target to Preclinical Drug Candidates. Journal of Medicinal Chemistry 59:1, pages 16-41.
Crossref
Erik De Clercq. (2015) Development of antiviral drugs for the treatment of hepatitis C at an accelerating pace. Reviews in Medical Virology 25:4, pages 254-267.
Crossref
Juan Francisco Sánchez-Ávila. (2015) Mexican Consensus on the Diagnosis and Management of Hepatitis C Infection. Annals of Hepatology 14, pages S7-S48.
Crossref
Trang H. Au, Christopher J. Destache & Renuga Vivekanandan. (2015) Hepatitis C therapy: Looking toward interferon-sparing regimens. Journal of the American Pharmacists Association 55:2, pages e72-e86.
Crossref
Kerstin Herzer. (2015) Hepatitis C virus reinfection after liver transplant: New chances and new challenges in the era of direct-acting antiviral agents. World Journal of Hepatology 7:3, pages 532.
Crossref